NanoSight NS300
Published August 10, 2022 · Recall initiated: April 7, 2022
Summary
FDA records medical device Class II recall Z-1442-2022, published August 10, 2022 and initiated April 7, 2022. Recalling firm: MALVERN PANALYTICAL LTD; Status: Ongoing; Reported quantity: 507 units; Lot: CDRH accession #0510530-003. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product found to not comply to Class 1 Laser safety requirement.
What to do
FDA Mandated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- MALVERN PANALYTICAL LTD
- Distributor
- US Nationwide - Worldwide Distribution
- Lot
- CDRH accession #0510530-003
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United Kingdom
Related recalls
- FDAVicks ZzzQuil Liquid Melatonin Syrup Adult 8oz plastic bottle sold as single and twin packAugust 10, 2022
- FDAPRESTIGE RETRACTION GRASPER, W/PORT DUAL ACTION, ROTATING 5mm DIAM., 36cm LENGTH. Product Code 8361-10August 10, 2022
- FDAVicks ZzzQuil Liquid Melatonin Syrup Pediatric 8oz plastic bottle sold as single and twin packAugust 10, 2022
- FDACustMbite, Model Number CBT-SRS-ULAugust 10, 2022
- FDAVicks Children's Botanicals Liquid Nighttime 4oz plastic bottleAugust 10, 2022
- FDAMerlin PCS 3650 programmer Model 3330 softwareAugust 10, 2022
Questions about this recall
Was NanoSight NS300 recalled?
Yes. FDA published recall Z-1442-2022 on August 10, 2022. Reported hazard: Product found to not comply to Class 1 Laser safety requirement.
What should I do if I have this product?
FDA Mandated · Letter